Treatment of Empyema with Elevated ADA Levels

Understanding ADA Levels in Empyema

The American Thoracic Society suggests that ADA ≥40 U/L in pleural fluid strongly suggests tuberculous etiology with 93% sensitivity and 97% specificity 1, 3
ADA alone cannot definitively distinguish between tuberculous and bacterial empyema, and clinical context, cell differential, and microbiological studies are essential 1

The American College of Chest Physicians recommends immediate chest tube drainage for tuberculous empyema, which contains large numbers of bacilli and requires drainage in addition to chemotherapy 2
The British Thoracic Society suggests inserting a chest tube connected to an underwater seal drainage system, kept below chest level at all times, and not clamping a bubbling chest drain 4
The Centers for Disease Control and Prevention recommend initiating a 6-month antituberculous regimen immediately for tuberculous empyema, consisting of an intensive phase (2 months) with rifampin, isoniazid, pyrazinamide, and ethambutol, and a continuation phase (4 months) with rifampin and isoniazid 2, 3
The American Thoracic Society recommends intrapleural fibrinolytics (urokinase) for loculated empyema, with a dose of 40,000 units in 40 mL saline twice daily for 3 days (6 doses total) for patients ≥10 kg 4
The Infectious Diseases Society of America suggests that corticosteroids do not prevent pleural thickening in tuberculous pleurisy and should not be used routinely for this indication 2

The American College of Chest Physicians advises against relying on ADA alone for diagnosis, as elevated ADA occurs in both tuberculous and bacterial empyema, as well as other conditions 1
The British Thoracic Society recommends against delaying drainage while awaiting TB culture results, as cultures take weeks but drainage is immediately necessary 4
The Centers for Disease Control and Prevention suggest that treatment outcome for tuberculous empyema is less satisfactory than pulmonary TB, requiring vigilant monitoring 3
The American Thoracic Society recommends weekly clinical assessment during the first month, looking for fever resolution, weight stabilization, and dyspnea improvement, and repeat imaging at 4 weeks to assess effusion size and early constriction signs 3